The microbial metabolite butyrate serves as a link between the intestinal microbiome and
epithelium. The monocarboxylate transporters MCT1 and SMCT1 are the predominant …

The gastrointestinal tract harbors numerous commensal bacteria, referred to as the
microbiota, that benefit host health by digesting dietary components and eliminating …

The connection between the gut microbiota and the aetiology of obesity and cardiometabolic
disorders is increasingly being recognized by clinicians. Our gut microbiota might affect the …

In recent years, there has been an increase in the use of organic acids as substitutes for
antibiotic growth promoters because of the fear of antibiotic resistance and the implications …

Background Gut microbiota dysbiosis has been linked to obesity-associated chronic
inflammation. Microbiota manipulation may therefore affect obesity-related comorbidities …

The human gut is the natural habitat for a large and dynamic bacterial community, but a
substantial part of these bacterial populations are still to be described. However, the …

This report will review the history of antibiotic growth promoter (AGP) use in the animal
industry, concerns about development of antimicrobial resistance, and response in the …

The gut is an obvious target for the development of functional foods, acting as it does as the
interface between diet and the metabolic events which sustain life. The key processes in …

Approvals for the use of nontherapeutic antibiotics in animal feed are fast disappearing
worldwide. The primary effect of antibiotics is antimicrobial; all of the digestibility and …

Organic acids and their salts appear to be potential alternatives to prophylactic in-feed
antibiotics and growth promoters in order to improve the performance of weaned piglets …